Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

<p>Modifications to vaccine delivery that increase serum antibody longevity are of great interest for maximizing efficacy. We have previously shown that a delayed fractional (DFx) dosing schedule (0-1-6 month) — using AS01<sub>B</sub>-adjuvanted RH5.1 malaria antigen &...

Full description

Bibliographic Details
Main Authors:	Nielsen, CM, Barrett, JR, Davis, C, Fallon, JK, Goh, C, Michell, AR, Griffin, C, Kwok, A, Loos, C, Darko, S, Laboune, F, Tekman, M, Diouf, A, Miura, K, Francica, JR, Ransier, A, Long, CA, Silk, SE, Payne, RO, Minassian, AM, Lauffenburger, DA, Seder, RA, Douek, DC, Alter, G, Draper, SJ
Format:	Journal article
Language:	English
Published:	American Society for Clinical Investigation 2023

Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

Similar Items